Clinical failure of nanoparticles in cancer: mimicking nature's solutions.
暂无分享,去创建一个
Macarena Perán | Pablo Hernández-Camarero | Víctor Amezcua-Hernández | Gema Jiménez | María A García | Juan A Marchal | J. Marchal | M. Perán | G. Jiménez | María A García | Pablo Hernández-Camarero | V. Amezcua-Hernández
[1] Fan Zhang,et al. Highly biocompatible zwitterionic phospholipids coated upconversion nanoparticles for efficient bioimaging. , 2014, Analytical chemistry.
[2] P. Kantoff,et al. Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.
[3] V. Palanisamy,et al. Horizontal transfer of RNAs: exosomes as mediators of intercellular communication , 2012, Wiley Interdisciplinary Reviews - RNA.
[4] Peixuan Guo,et al. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy. , 2018, Cancer letters.
[5] Yongjiang Zheng,et al. Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells , 2017, Front. Pharmacol..
[6] H. Maeda,et al. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.
[7] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[8] Shuming Nie,et al. Understanding and overcoming major barriers in cancer nanomedicine. , 2010, Nanomedicine.
[9] S. Tenzer,et al. Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons? , 2007, Proteomics. Clinical applications.
[10] D. Simberg,et al. Nanoparticle transport pathways into tumors , 2018, Journal of Nanoparticle Research.
[11] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[12] Biao Lu,et al. Development of exosome surface display technology in living human cells. , 2016, Biochemical and biophysical research communications.
[13] Shuai Liu,et al. Virus Spike and Membrane-Lytic Mimicking Nanoparticles for High Cell Binding and Superior Endosomal Escape. , 2018, ACS applied materials & interfaces.
[14] E. Graves,et al. Theranostic nanoparticles enhance the response of glioblastomas to radiation , 2019, Nanotheranostics.
[15] S. Krishnan,et al. Nanoparticle-mediated hyperthermia in cancer therapy. , 2011, Therapeutic delivery.
[16] Myung Soo Kim,et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[17] Hui-zhen Jia,et al. Cancer-targeted functional gold nanoparticles for apoptosis induction and real-time imaging based on FRET. , 2014, Nanoscale.
[18] Jennifer C Jones,et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. , 2016, Biomaterials.
[19] Keith L Ligon,et al. Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.
[20] Tian Zhang,et al. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy , 2017, Nature Nanotechnology.
[21] E. S. Day,et al. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management , 2019, Cancers.
[22] M. Eblan,et al. Clinical Translation of Nanomedicine. , 2015, Chemical reviews.
[23] S. Simões,et al. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. , 2012, Accounts of chemical research.
[24] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[25] A. Gaharwar,et al. Engineered Extracellular Vesicles with Synthetic Lipids via Membrane Fusion to Establish Efficient Gene Delivery. , 2019, International journal of pharmaceutics.
[26] J. Marchal,et al. A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer. , 2020, Nanomedicine : nanotechnology, biology, and medicine.
[27] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[28] C. Su,et al. Design strategies and application progress of therapeutic exosomes , 2019, Theranostics.
[29] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[30] A. Lamprecht,et al. Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin. , 2015, International journal of pharmaceutics.
[31] E. Batrakova,et al. Development and regulation of exosome-based therapy products. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[32] K. Peter,et al. Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies. , 2017, Nanomedicine.
[33] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.
[34] Asier Unciti-Broceta,et al. Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis , 2019, Nature Catalysis.
[35] F. Castellino,et al. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. , 2007, Blood.
[36] Manho Kim,et al. Low pH increases the yield of exosome isolation. , 2015, Biochemical and biophysical research communications.
[37] E. Aboagye,et al. Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. , 2013, Chemical Society reviews.
[38] H. Daniel Ou-Yang,et al. The influence of size, shape and vessel geometry on nanoparticle distribution , 2013, Microfluidics and nanofluidics.
[39] Dennis E Discher,et al. Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .
[40] H. Gendelman,et al. Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases , 2013, PloS one.
[41] Ronnie H. Fang,et al. Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.
[42] M. Pittenger,et al. Concise Review: MSC‐Derived Exosomes for Cell‐Free Therapy , 2017, Stem cells.
[43] S. Lai,et al. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[44] V. Zharov,et al. Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances , 2014, Scientific Reports.
[45] S. Lim,et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.
[46] Joshua L Hood. Post isolation modification of exosomes for nanomedicine applications. , 2016, Nanomedicine.
[47] J. Vandesompele,et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling , 2014, Journal of extracellular vesicles.
[48] Qiang He,et al. Stem Cell Membrane-Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery. , 2016, Small.
[49] R. Ramesh,et al. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. , 2016, Journal of biomedical nanotechnology.
[50] Mutsa P. Seremwe,et al. A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial Reagents , 2017, PloS one.
[51] Tomasz Deptuch,et al. Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells , 2020, Journal of Nanobiotechnology.
[52] Da Ma,et al. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. , 2014, Nanoscale.
[53] P. Rai,et al. Nanoparticle Design Strategies for Effective Cancer Immunotherapy. , 2017, Journal of Biomedicine.
[54] Ronnie H. Fang,et al. Cell Membrane Coating Nanotechnology , 2018, Advanced materials.
[55] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[56] Hao Cheng,et al. A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles , 2016, Theranostics.
[57] P. Mishra,et al. Metal nanoparticles: a theranostic nanotool against cancer. , 2015, Drug discovery today.
[58] V. Rotello,et al. Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.
[59] Jie Zheng,et al. Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.
[60] K. Pienta,et al. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis , 2019, The Journal of experimental medicine.
[61] M. Soleimani,et al. Targeted delivery of doxorubicin to HER2 positive tumor models , 2019, International journal of nanomedicine.
[62] J. Ryu,et al. Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer , 2018, Gut and liver.
[63] T. Maheswaran,et al. Theranostics: A treasured tailor for tomorrow , 2014, Journal of pharmacy & bioallied sciences.
[64] Richard J. Simpson,et al. Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature* , 2009, Molecular & Cellular Proteomics.
[65] M. Logozzi,et al. Exosomes: the ideal nanovectors for biodelivery , 2013, Biological chemistry.
[66] Wei Wei,et al. Biomimetic Immuno‐Magnetosomes for High‐Performance Enrichment of Circulating Tumor Cells , 2016, Advanced materials.
[67] Samuel A Wickline,et al. Maximizing exosome colloidal stability following electroporation. , 2014, Analytical biochemistry.
[68] Y. Pei,et al. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[69] Kinam Park,et al. Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.
[70] Ronnie H. Fang,et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.
[71] D. L. Cooper,et al. Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity , 2014, Expert opinion on drug delivery.
[72] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[73] T. Berg,et al. Innate immune ‘self’ recognition: a role for CD47–SIRPα interactions in hematopoietic stem cell transplantation , 2008 .
[74] J. Schorey,et al. Ubiquitination as a Mechanism To Transport Soluble Mycobacterial and Eukaryotic Proteins to Exosomes , 2015, The Journal of Immunology.
[75] K. Thiel,et al. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. , 2019, Gynecologic oncology.
[76] Shi Hu,et al. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity , 2019, Nature Communications.
[77] Ronnie H. Fang,et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. , 2013, Nanoscale.
[78] Jian-Bing Fan,et al. miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles , 2012, Molecular therapy. Nucleic acids.
[79] V. Sanna,et al. Targeted therapy using nanotechnology: focus on cancer , 2014, International journal of nanomedicine.
[80] Ronnie H. Fang,et al. Biomimetic strategies for targeted nanoparticle delivery , 2016, Bioengineering & translational medicine.
[81] Z. Guan,et al. Construction of targeting nanoparticle of 3',3''-bis-peptide-siRNA conjugate/mixed lipid with post-inserted DSPE-PEG2000-cRGD. , 2019, Molecular pharmaceutics.
[82] R. Jain,et al. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.
[83] K. Drescher,et al. Exosomal miRNAs: Biological Properties and Therapeutic Potential , 2012, Front. Gene..
[84] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[85] S. Kopetz,et al. Platelets, circulating tumor cells, and the circulome , 2017, Cancer and Metastasis Reviews.
[86] Chuan Yang,et al. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles. , 2013, Biomaterials.
[87] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[88] Lei Zhang,et al. Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. , 2012, ACS nano.